Search research articles
Contact Us
Filters
Showing results (111-120 of 306) with videos related to
Page
of 31
Sort By:
British Journal of Clinical Pharmacology
|
February 15, 2007
The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example
Gemma L Dickinson, Martin S Lennard, Geoffrey T Tucker, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 20, 2004
Predicting the clearance of CYP2C9 substrates
Karen Rowland Yeo, Eleanor M Howgate, Geoffrey T Tucker, et al.
The AAPS Journal
|
July 19, 2020
Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models
Dan Liu, Linzhong Li, Amin Rostami-Hodjegan, et al.
International Immunopharmacology
|
January 23, 2003
Influence of the thr164ile polymorphism in the beta2-adrenoceptor on the effects of beta-adrenoceptor agonists on human lung mast cells
Linda J Kay, Lee K Chong, Amin Rostami-Hodjegan, et al.
Clinical Pharmacokinetics
|
April 21, 2012
Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling
Khaled Abduljalil, Penny Furness, Trevor N Johnson, et al.
Drug Metabolism and Pharmacokinetics
|
May 30, 2016
Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro data
Lu Gaohua, Sibylle Neuhoff, Trevor N Johnson, et al.
The AAPS Journal
|
June 18, 2016
Examining the Use of a Mechanistic Model to Generate an In Vivo/In Vitro Correlation: Journey Through a Thought Process
Bipin Mistry, Nikunjkumar Patel, Masoud Jamei, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 31, 2022
Examining Physiologically Based Pharmacokinetic Model Assumptions for Cross-Tissue Similarity of Activity per Unit of Enzyme: The Case Example of Uridine 5'-Diphosphate Glucuronosyltransferase
Anika N Ahmed, Amin Rostami-Hodjegan, Jill Barber, et al.
Biopharmaceutics & Drug Disposition
|
January 1, 2017
Quantifying gut wall metabolism: methodology matters
Oliver J D Hatley, Christopher R Jones, Aleksandra Galetin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 5, 2017
Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing Enzymes
Brahim Achour, Hajar Al Feteisi, Francesco Lanucara, et al.
Page
of 31
Search research articles
Search
Showing results (111-120 of 306) with videos related to
Sort By:
Page
of 31
British Journal of Clinical Pharmacology
|
February 15, 2007
The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example
Gemma L Dickinson, Martin S Lennard, Geoffrey T Tucker, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 20, 2004
Predicting the clearance of CYP2C9 substrates
Karen Rowland Yeo, Eleanor M Howgate, Geoffrey T Tucker, et al.
The AAPS Journal
|
July 19, 2020
Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models
Dan Liu, Linzhong Li, Amin Rostami-Hodjegan, et al.
International Immunopharmacology
|
January 23, 2003
Influence of the thr164ile polymorphism in the beta2-adrenoceptor on the effects of beta-adrenoceptor agonists on human lung mast cells
Linda J Kay, Lee K Chong, Amin Rostami-Hodjegan, et al.
Clinical Pharmacokinetics
|
April 21, 2012
Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling
Khaled Abduljalil, Penny Furness, Trevor N Johnson, et al.
Drug Metabolism and Pharmacokinetics
|
May 30, 2016
Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro data
Lu Gaohua, Sibylle Neuhoff, Trevor N Johnson, et al.
The AAPS Journal
|
June 18, 2016
Examining the Use of a Mechanistic Model to Generate an In Vivo/In Vitro Correlation: Journey Through a Thought Process
Bipin Mistry, Nikunjkumar Patel, Masoud Jamei, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 31, 2022
Examining Physiologically Based Pharmacokinetic Model Assumptions for Cross-Tissue Similarity of Activity per Unit of Enzyme: The Case Example of Uridine 5'-Diphosphate Glucuronosyltransferase
Anika N Ahmed, Amin Rostami-Hodjegan, Jill Barber, et al.
Biopharmaceutics & Drug Disposition
|
January 1, 2017
Quantifying gut wall metabolism: methodology matters
Oliver J D Hatley, Christopher R Jones, Aleksandra Galetin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 5, 2017
Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing Enzymes
Brahim Achour, Hajar Al Feteisi, Francesco Lanucara, et al.
Page
of 31